0
GILD
Gilead Sciences, Inc.
Market Cap
$83,519,779,851.00
52 Week High
$86.09
PE Ratio
14.746
52 Week Low
$65.90
EPS
$4.50
Shares Outstanding
1,245,077,219.00
Dividend Yield
4.37%
Dividend Per Share
$2.93
PoweredByInsightfulIR
GILD - Top Posts
Image

Manifest Investing 06/08/2022

GILD, Buy

Gilead Sciences,...
Return: 7.78%

GILD, Buy

Return: 7.78%

Recreating our portfolio here at STOCKbossUP!

The tracking portfolio has an annualized total return (since July 2010) of 16.0%.

Visit https://www.manifestinvesting.com/dashboards/public/round-table...

Read More

Image

North Carolina 04/19/2022

GILD, Closed

Gilead Sciences,...
Return: -6.48%

GILD, Closed

Return: -6.48%
**POSITION UPDATE**

Getting out of this company.

Image

WNE TeamUP Spring 2020 03/24/2020

GILD, Closed

Gilead Sciences,...
Return: -10.44%

GILD, Closed

Return: -10.44%
**POSITION UPDATE**

Image

WNE TeamUP Spring 2020 03/04/2020

GILD, Buy

Gilead Sciences,...
Return: -10.44%

GILD, Buy

Return: -10.44%

Image

Moguls In Training 10/23/2020

GILD, Buy

Gilead Sciences,...
Return: 5.84%

GILD, Buy

Return: 5.84%

Pharma

Image

Louisiana 05/09/2020

GILD, Buy

Gilead Sciences,...
Return: -13.75%

GILD, Buy

Return: -13.75%

I’ve been keeping my eye on this particular stock!

Image

Freshman Seminar Fall 2020 09/14/2020

GILD, Buy

Gilead Sciences,...
Return: 4.10%

GILD, Buy

Return: 4.10%

gains another promising drug strengthened its cancer portfolio

Image

North Carolina 08/03/2020

GILD, Buy

Gilead Sciences,...
Return: -6.48%

GILD, Buy

Return: -6.48%

Also adding more healthcare to the portfolio as well.

Image

Intro to Finance Fall 2020 09/14/2020

GILD, Buy

Gilead Sciences,...
Return: 0.06%

GILD, Buy

Return: 0.06%

Acquisition of large biopharmaceutical company

Image

California 11/03/2020

GILD, Buy

Gilead Sciences,...
Return: 14.02%

GILD, Buy

Return: 14.02%

A few weeks ago, when Remdesivir, a anti retro viral medication, was discovered to be ineffective in treating Covid 19, stocks seem to slip more than the economic downturn prompted. I’m interested to ...

Read More

Latest News